Express Scripts says its largest plan will cover only AbbVie's hepatitis C regimen, excluding drugs from Gilead and J&J.» Read More
To give investors an edge, CNBC asked market experts to share their best retail plays.
Find out if these viewers are investing according to Mad Money's most important rule.
A steady stream of downbeat news seemed to leave the market unmoved for most of the week -- until the bluest of the blue chips, General Electric, posted first-quarter earnings that missed Wall Street expectations by seven cents per share, and lowered its full-year guidance.
With other blue-chip companies due to report earnings in the coming week, GE's disappointing results fueled worries that the bad news may be just beginning.
A double helping of economic data and first-quarter earnings reports will flood the zone next week, but it's the corporate earnings that will drive stocks and give a better picture of where the economy is going. If GE's bombshell earnings miss is an indicator, the news will be as nasty as traders expect.
In Friday’s Web Extra find out how the traders are playing the earnings deluge coming in the week ahead.
While passing the Olympic torch has become a focal point for demonstrations over China's human rights record, major sponsors of the games aren't expected to flame out over the controversy.
Dow Jones has created a Summer Games Index to track the companies involved in the Olympics. How is it reacting to the protests?
Plus, Intel drags down tech, breaking news from American Airlines and UPS and much more.
After a rough start, top investment officers are looking for gradual improvement as 2008 goes on. Harbor Advisory's Jack DeGan is among them, and he won't sugar-coat the current situation.
The Star-Ledger of New Jersey this weekend did a story that I think provides the best insight and backstory about what happened last week at the highest levels of Schering-Plough.CEO Fred Hassan was in Miami when doctors dropped the bomb on Vytorin and Zetia at the American College of Cardiology meeting.
CEO Fred Hassan updates investors on his company's plans to rebound from the Vytorin debacle.
Microsoft vs. Apple is just one of the exciting match-ups in this round of the Fast Money Madness tournament. Find out which companies make it to the Final Four.
Options activity is picking up in Johnson & Johnson stock. Why?
Somebody’s got to go. Find out who’s packing their bags and heading home in the Fast Money Madness tournament. In this round the traders slug it out in the Tech & Telecom and Health & Home sectors.
Ahead of the world's biggest gathering of cardiologists in Chicago this weekend, there's a flurry of news about stents--the expensive little wire mesh tubes that prop open clogged arteries. First, the Food and Drug Administration has posted new proposed guidelines for pre-and post-market testing of the controversial devices.
When it comes to the big business of celebrity gossip, a Hilton is cashing in, and I'm not talking Paris. I'm talking PEREZ, the self-dubbed 'Queen of Media.' Born Mario Lavandeira, Hilton named his persona after the ultimate celebrity who's famous for simply being famous, and created one of THE most successful celebrity gossip blogs.
As proxy statements pop up on www.sec.gov, investors can get a peek at who's making what. When you go to the web site, click on "Search for company filings," then click on "Companies and other filers," enter the ticker symbol, click on "Find companies" and then open up the "14A" or proxy statement.
"Do as I do, not as I say" That’s, the motto behind a little segment we like to call whale watching where we profile the world's most successful investors - a.k.a whales - and try to find out if you can trade in their wake.
Tuesday's explosive stock rally, fueled by the Fed's latest efforts to stem the credit crisis, is convincing more on Wall Street that the market may finally be nearing a bottom.